Purpose of Review Organism identification and antibiotic selection remain a critical component of periprosthetic joint infection (PJI) treatment. Prior to organism identification and/or the availability of antibiotic sensitivities, empiric antibiotics are routinely started. A basic understanding of a region or institutions antibiogram is paramount for selection of an empiric treatment regimen. Evolving antibiogram results and regional antibiotic resistance are important to follow as this may change antibiotic selection in some patient populations. Recent Findings The Clinical Laboratory and Standards Institute (CLSI) has created guidelines and standards for the creation and maintenance of antibiograms that should be followed by institutions. The infecting organism during PJI may be different in acute vs chronic infections and empiric therapy may change depending on the timing. Antibiotic prophylaxis for major procedures in certain patient populations should be critically evaluated based on regional and national antibiogram results. Summary The CLSI guides recommendations and antibiotic resistance testing techniques and should be consulted when creating an antibiogram. The local and regional antibiogram should be consulted prior to administration of empiric and prophylactic antibiotics.
Introduction
Periprosthetic joint infection (PJI) rates remain relatively low but continue to account for significant patient morbidity and mortality [1] . PJI has been reported to be the most common indication for revision total knee arthroplasty (TKA) and the third most common indication for revision total hip arthroplasty (THA) [2] . Treatment of infection after total joint arthroplasty requires substantial hospital resources and represents a high cost to the system [3••, 4, 5] .
Proper identification of the offending organism is paramount, with antibiotic sensitivities obtained after organism identification being necessary for guiding long-term antibiotic selection [6] . The proper antibiotic varies from organism to organism and is determined by the sensitivities of the organism to available antibiotics, route of antibiotic selected, side effects, and bioavailability of the antibiotic [7] .
Empiric antibiotic therapy is often utilized while bacterial antibiotic sensitivities are pending [7] . Many institutions and regions have cumulative antibiograms created by testing antibiotic sensitivities of previously infecting organisms that have been treated in the institution or region [8] . Cumulative antibiograms represent the general sensitivity of antibiotics to commonly infecting organisms and can be an invaluable resource while sensitivities are pending (Fig. 1) . This paper will be a general review of antibiotic susceptibility testing, antibiograms, and their applicability to the orthopedic surgeon.
The Clinical Laboratory and Standards Institute and M39-A Document
The Clinical and Laboratory Standards Institute (CLSI) is an internationally recognized organization that establishes guidelines for pathogen growth and antimicrobial susceptibility testing. Antibiotic sensitivities are based on and performed using the CLSI guidelines and antibiotic breakpoints. The antibiotic breakpoint is the chosen concentration of antibiotic which defines whether or not the bacteria is susceptible to the antibiotic [9] . If the minimum inhibitory concentration (MIC) of the organism is lower or equal to the antibiotic breakpoint, the organism is considered susceptible to the antibiotic [9] .
In 2000, the CLSI created a standard for creating cumulative antibiograms called the CLSI M39-A. Prior to this, states and hospitals created antibiograms using their own individualized techniques that did not allow for comparison of antibiograms between institutions or states. Currently, hospitals and states are encouraged to create cumulative antibiograms using these standards. The CLSI M39-A4 is now available and evaluates the most updated susceptibilities and ongoing surveillance of clinically significant organisms [7] . The M39-A document is updated approximately every 4 to 5 years and is commercially available through the CLSI [10] .
The M39-A document gives specific recommendations on a variety of variables associated with creating antibiograms such as the frequency of reporting, minimum number of isolates to test for an accurate susceptibility, exclusion of screening cultures from reports, which antibiotics to test, data stratification based on department (i.e., intensive care units vs. medical floor), and how to manage repeat isolates from patients [10, 11] . It also has recommendations on recording and reporting techniques. Currently, it is recommended to record both the qualitative (i.e., sensitive, intermediate, and resistant classifications) data as well as the quantitative data such as the MIC and diameter of inhibition zones. The documentation of these variables is important to record for when the antimicrobial breakpoint of certain organisms changes over time. The M39-A document also suggests presentation of data as percent of isolates susceptible. It is recommended that isolates with intermediate susceptibility to an antimicrobial not be included as a susceptible organism for percent susceptibility calculation because many physicians will not prescribe an antibiotic that has intermediate susceptibility [10] . 
Antibiotic Susceptibility Testing Techniques

Broth Dilution
The original broth dilution technique utilized a tube-dilution method. This technique involved preparing a series of tubes with progressively diluted antibiotic concentrations in broth media. Each tube was inoculated with a known standard concentration of bacteria [12] . Tubes were then incubated overnight at 35°C and evaluation of turbidity in each tube performed. The lowest antibiotic concentration that did not allow for bacterial growth was determined to be the minimum inhibitory concentration (MIC).
Due to the expense, labor-intensive methodology, and large variability of MIC between samples using the tube-dilution technique, modifications of the technique were implemented to perform this test in 96-well microdilution plates [13, 14] . This has allowed eight dilutions of an antibiotic to be evaluated on one plate. A "master" dilution of commonly tested antibiotics prepared in the laboratory can be created and pipetted using precise instrumentation into the plates for susceptibility testing. Currently, commercially available, premade antibiotic 96-well plates are available for purchase, so individual labs do not have to create stock solutions of diluted antibiotics. With premade plates, the laboratory pipettes the standard bacterial concentration into the wells using their preferred aliquot dispensing system without having to create the dilute antibiotic solutions. After incubation, a manual or automated viewer is used to evaluate the MIC in the 96-well plate. This methodology has improved the reproducibly of the broth dilution methodology and has decreased the overall costs associated with susceptibility testing [13] .
Disk Diffusion
This technique involves evenly plating a known concentration of a bacterium on a Mueller-Hinton agar plate. Commercially available antibiotic disks are then placed on the agar and incubated for up to 24 h [15] . Clearance around the disk is measured to the nearest millimeter with the diameter of the clearance related to the susceptibility of the bacteria to the tested antibiotic. The CLSI has predefined and published standards regarding the diameter of the clearance around the disk as it relates the susceptibility of the bacteria [16] . Disk diffusion does not give a MIC number, but rather a qualitative result. Using the CLSI standards, the bacteria is rated as either susceptible, intermediate, or resistant to the tested antibiotic [16] . Disk diffusion is a cost effective and easily interpreted technique, but is limited by the lack automation and inability to report a MIC. The disk diffusion technique may not be reliable when evaluating slow growing organisms; however, this technique can be utilized using preset agar and growth conditions for testing organisms such as streptococci.
Antimicrobial Diffusion Gradients
Evaluating susceptibilities using antibiotic diffusion gradients obtains a MIC by creating an antibiotic diffusion gradient in the agar [14] . A known concentration of bacteria is evenly plated on an agar plate, and a commercially available Etest strip (bioMe'rieux AB BIODISK) is placed on the agar. The Etest strip is a plastic strip impregnated with a dried antibiotic gradient with the associated antibiotic concentration printed on the front for easy visualization of MICs [17] . After agar plate incubation, a zone of clearing is established around the Etest strip similar to the disk diffusion technique. The intersection of the lowest part of the elliptical zone of clearing around the Etest strip is visualized, and the associated antibiotic concentration printed on the strip is determined to be the MIC [17] . The cost of the strips is a limitation of this technique, with the Etest technique being best utilized when only a few antibiotics are required for testing. MICs from the Etest technique, in general, correlate well with MICs obtained from broth dilution techniques, but may vary with certain bacteriaantibiotic concentrations [18] .
Commercial Automated Systems
The use of automated optical detection systems allows for a more sensitive and rapid determination of MICs. These systems are often associated with computer software that assists in interpreting test results [14] . Thirty to 240 simultaneous tests can be performed depending on the company, with sensitivities available in 3.5-24 h depending on the system and technique utilized. Each automated system uses proprietary sensors and detection techniques to determine bacterial growth in well-plates specific for each automated system. Rapid determination of antibiotic susceptibilities may be associated with decreased costs associated with laboratory staffing, a faster determination of organism specific antibiotics, and decreased length of stay [14, 19] .
Clinical Applications
Periprosthetic joint infection is associated with increased utilization of healthcare resources [4, 20] . Specific organisms may predispose to even higher costs. Parvizi et al. performed a multicenter study to specifically evaluate the in-hospital costs of PJI associated with methicillin-resistant (MRSA) organisms compared to methicillin-sensitive organisms [5] . They showed an increase in number of hospitalizations, total number of hospital days, mean length of stay, and higher inpatient cost for treating PJI associated with MRSA. Due to the high cost of treating patients with staphylococcal infections, local antibiograms may be useful for following trends in resistant patterns of infection in order to identify possible areas that require local infection prevention interventions.
Antibiograms provide a valuable reference for surgeons managing periprosthetic joint infection by informing the surgeon what organisms are commonly presenting in their community with their associated antibiotic susceptibilities. While empiric antibiotics typically cover common organisms, understanding local and regional variability in bacteria and antibiotic resistance can assist the clinician in selecting antibiotics. Furthermore, careful re-evaluation of antibiotic protocols should be scheduled routinely to ensure that subtle changes in organism prevalence and susceptibility are accounted for.
Studies have evaluated common organisms and antibiotic resistance [21, 22] . Fulkerson et al. reviewed 194 culture positive specimens from patients undergoing reoperation following THA and TKA [21] . Gram-positive organisms represented the majority of those cultured (35% Staphylococcus aureus, 31% Staphylococcus epidermidis, 11% Streptococcus). The mean time to culture positive results was 3 days. Interestingly, antibiotic sensitivity varied based on classification of infection: (1) acute postoperative infections, (2) chronic infection (> 4 weeks postoperatively), and (3) hematogenous. In their series, acute postoperative infections had the highest rate of antibiotic resistance. They also noted that regional variation in species was significant among their population although antibiotic sensitivity remained similar. Cefazolin was only sensitive in 61% of the isolates; however, the majority of gram-positive organisms were sensitive to vancomycin.
Internationally, there have been several studies evaluating patterns of infection. Aamot et al. reviewed Staphylococcus aureus species isolated from all orthopedic patients over a 12-year period of time in Norway [22] . They noted no shift in geno-and phenotypes over time or antibiotic susceptibility over time. Oppegaard et al. reviewed data from their entire hospital system, including all patients, in Norway between 1999 and 2013 and noted a significant increase in group C and G Streptococci [23] . Ip et al. identified an increase in multiple-drug-resistant bacteria isolated from periprosthetic joint infections in Hong Kong [24] . These international variations and trends in isolated organisms and susceptibilities parallel national and regional findings.
One particular area of interest for antibiograms is selecting appropriate prophylactic coverage for high-risk patients, such as those with immunocompromised states, and those with allergies to traditional antibiotic prophylaxis. The most commonly recommended antibiotics for prophylaxis are cefazolin and cefuroximine for routine orthopedic procedures [25] . Vancomycin and clindamycin are reasonable alternatives for patients with an allergy to cephalosporins; however, understanding the local antibiogram can help tailor prophylaxis to accommodate variations in antibiotic resistance. Clindamycin is a bacteriostatic agent, and while it provides reasonable coverage for most gram-positive organisms, caution should be taken with its use as a surgical prophylactic since it is not as effective as vancomycin for MRSA, methicillin sensitive S. aureus (MSSA), and resistant patterns in low virulence organisms such as Propionibacterium acnes have been noted [25-27, 28•] . Vancomycin, while bacteriocidal with more effective MRSA coverage, lacks gram-negative coverage [25, 26, 29•] . Tan et al. retrospectively reviewed 10,391 primary total joint arthroplasties to determine whether vancomycin alone for prophylaxis in patients with penicillin allergy was associated with an increased risk of infection. They did note that there was a reduced risk of infection with gram-positive organisms and antibiotic-resistant organisms with vancomycin [26] . While some have advocated expanding coverage with the routine use of vancomycin as a dual therapy, side effects such as acute kidney injury have been reported with variable data on improved outcomes [25, 30] . Additionally, broadening preoperative antibiotic coverage may induce resistant organism over time and should always be used with caution.
An alternative approach to routine dual therapy is antibiogram-specific coverage. Bosco et al. noted that 30% of surgical site infections following hip arthroplasty at their institution were caused by gram-negative bacilli, 44% of which were resistant to cefazolin [31••] . They adjusted their protocol to include gram-negative coverage with either weight-based gentamicin or aztreonam and noted a decrease in overall rate of surgical site infection from 1.19 to 0.55% after. This study suggests the importance of routine surveillance of SSI and updated antibiograms to improve prophylactic regimens tailored to patterns in local organisms. Tan et al. performed a multivariate analysis to determine if patientspecific comorbidities influenced the organism profile of PJIs and whether the effectiveness cefazolin or vancomycin as prophylaxis varied by comorbidity [29•] . They did not show a difference in PJI rate between either monotherapy, and no comorbidity was associated with an increased rate of gram-positive or gram-negative infection. Interestingly, they did show an increase in antibiotic-resistant organisms with metastatic disease, diabetes mellitus, and chronic pulmonary disease.
As we continue to develop more robust registry data, one potential future application may reasonably include organisms isolated for periprosthetic joint infection as well as antibiotic susceptibility. This data would then be able to create a more comprehensive national antibiogram and ultimately aid in clinical decision-making around appropriate antibiotic utilization.
Limitations of Antibiograms
Although antibiograms give an overview of susceptibility patterns, there are limitations when using this data [32] .
Antibiograms are aggregates of all organisms isolated in a region or hospital. Many often do not delineate what department they came from, or the location of the body the organism was identified [33] . For the orthopedist, this may result in determination of empiric antibiotic selection based off of strains more commonly isolated from superficial infections or central line infections rather than from periprosthetic infections. It is currently unclear if bacterial antibiotic susceptibilities vary between orthopedic and non-orthopedic strains of bacteria; as for example, when a staphylococcal organism causes a soft tissue abscess versus a PJI. Late periprosthetic orthopedic infections may be caused by a remote infection in the body with subsequent hematogenous spreading, so an understanding of the overall susceptibility patterns in the treating physician's region may still be beneficial despite the lack of orthopedic specific susceptibility patterns. Additionally, not all antibiotics are tested during antibiogram creation. Surrogate antibiotics are used in specific antibiotic classes such as the testing of oxacillin in lieu of cefazolin. This, in general, gives an accurate representation of susceptibility, but if a specific susceptibility of an antibiotic is needed, it may not be represented in the regional or institutional antibiogram. They also do not take into consideration the patient's infectious disease history or previous antibiotic usage. Antibiograms serve as a general guideline; however, the clinical scenario and any previously infecting organism with their associated susceptibilities must be considered when deciding what antibiotic to use.
Conclusion
In summary, antibiograms are a useful resource when determining what antibiotics to use for empiric therapy in many clinical scenarios. Although there are limitations to their use, an understanding of regional variations in antibiotic susceptibilities is important prior to empiric antibiotic selection while organism specific susceptibilities are pending. In addition to tracking antibiotic-resistant patterns to commonly infecting organism over time, local antibiograms may also be useful when determining antibiotic prophylaxis for high-risk patients, or patients with allergies that preclude them from receiving a first generation cephalosporin.
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